Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024Hong Kong Takes Key Step Towards Becoming a Medical Hub with New Clini...
  • 12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
  • 12/8/2024ChipScreen Announces Mixed Phase III Results for Chiauranib in SCLC Tr...
  • 12/8/2024BioNTech and DualityBio Unveil Promising Interim Results for Partnered...
  • 12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
  • 12/5/2024Cinclus Wins Marketing Approval in China for GERD Drug Linaprazan Glur...
  • 12/5/2024Abbisko’s PRMT5*MTA Inhibitor ABSK131 Granted IND Clearance from the ...
  • 12/4/2024Everest Medicines Announces Positive Results in Preliminary Analysis o...
  • 12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
  • 12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
  • 12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  
  • 12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
  • 12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
  • 11/27/2024Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug
  • 11/25/2024China's Real-World Data Pilot Drives Global Collaboration and Regulato...
  • 11/25/2024Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
  • 11/25/2024Zhongsheng Announces Promising Phase II Results for Weight Loss Drug R...
  • 11/21/2024China Strengthens Focus on Gene and Cell Therapy Research in Suzhou
  • 11/21/2024Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
  • 11/20/2024China-U.S. Health Experts Convene in Beijing to Address Cancer and Chr...
  • 11/19/2024China Grants Priority Review to Ascentage Pharma's Lisaftoclax NDA
  • 11/18/2024ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
  • 11/18/2024FDA Grants BTD to Huahui Health's Libevitug (HH-003) for Chronic HDV I...
  • Page:10/14 Total number of articles:409: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group